Innate Pharma buy metanicnor
Start price
07.09.14
/
50%
€8.63
Target price
09.03.15
€10.50
Performance (%)
19.99%
End price
09.03.15
€10.35
Summary
This prediction ended on 09.03.15 with a price of €10.35. The BUY prediction by metanicnor finished with a performance of 19.99%. metanicnor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innate Pharma | -3.252% | -3.252% | -27.879% | -52.495% |
| iShares Core DAX® | 0.193% | -1.216% | 8.843% | 58.517% |
| iShares Nasdaq 100 | -1.353% | -5.307% | -1.141% | 82.228% |
| iShares Nikkei 225® | -0.426% | 7.319% | 27.580% | 65.208% |
| iShares S&P 500 | -1.008% | -3.400% | -0.222% | 56.665% |
Comments by metanicnor for this prediction
In the thread Innate Pharma diskutieren
IPH Kauf
eines der wenigen Biotech-Unternehmen in der Welt auf der angeborenen Immunität positioniert
das Geld wird es ermöglichen, halten die Ende 2017
(Laufzeit überschritten)